Caricamento...
USL255 extended-release topiramate: Dose-proportional pharmacokinetics and tolerability in healthy volunteers
OBJECTIVE: Evaluate the pharmacokinetics (PK), safety, and tolerability of single doses of once-daily USL255, Qudexy XR (topiramate) extended-release capsules, over a wide dosing range. METHODS: Two single-dose, phase I studies in healthy adults were used to evaluate the PK profile and maximum toler...
Salvato in:
| Pubblicato in: | Epilepsia |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BlackWell Publishing Ltd
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4283972/ https://ncbi.nlm.nih.gov/pubmed/24861853 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/epi.12654 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|